SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19

Publications

Check out some interesting uses of the SpyTag/SpyCatcher technology

A study from Scripps using SpyTag/SpyCatcher technology shows that the receptor-binding domain and stabilized SARS-CoV-2 spike displayed on ferritin nanoparticles as vaccine antigens, elicited potent immune responses.

Click link here for the paper (14 Sept, 2020)


Covid-19 vaccine candidates using SpyCatcher/SpyTag to display Spike protein on computationally designed particles and Bacteriophage VLPs

Click here to read the full paper on computationally designed VLPs (31 Aug 2020)

Click here to read the full paper on Bacteriophage VLPs.


Read more about our pipeline and the diseases we are working to eradicate.

Our Pipeline